Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.

HLA - 1 Feb 2016

Zambra F M B, Biolchi V, de Cerqueira C C S, Brum I S, Castelli E C, Chies J A B

Abstract excerpt

Human leukocyte antigen G (HLA-G) is an immunomodulatory molecule with important roles both physiologically as well as an escape mechanism of cancer cells. In this study, we evaluated the impact of eight polymorphisms at the 3' untranslated region (3'UTR) of the HLA-G gene in the development of prostate cancer (PCa) and benign prostatic hyperplasia (BPH). A total of 468 DNA samples of Brazilian men predominantly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Case-Control Studies

Share to HLA-G Antigens

Share to Neoplasm Proteins

Share to Prostatic Hyperplasia

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 26889902
DOI: 10.1111/tan.12741

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.PMID 26889902Read ↗

Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study.Semantic proximity Read ↗

The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.Semantic proximity Read ↗

CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.Semantic proximity Read ↗

Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.Semantic proximity Read ↗

Association between circulating inflammatory proteins and benign prostatic disease: a Mendelian randomization study.Semantic proximity Read ↗

Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population.Semantic proximity Read ↗

Analysis of KIR gene frequencies and HLA class I genotypes in prostate cancer and control group.Semantic proximity Read ↗

The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.Semantic proximity Read ↗

Immunogenetics of prostate cancer: a still unexplored field of study.Semantic proximity Read ↗

Common variants at 8q24 are associated with prostate cancer risk in Serbian population.Semantic proximity Read ↗

Promising link of HLA-G polymorphism, tobacco consumption and risk of Head and Neck Squamous Cell Carcinoma (HNSCC) in North Indian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.